A center for research, development and production of biotechnology products, focused on the markets of Iran, Central Asia and the Middle East.
Production of biological raw materials
Development of recombinant drugs
Contract research services (CRO)
Contract development & manufacturing (CDMO)
Production of diagnostic kits
Development of cellular & molecular technologies
The global biotechnology market has reached hundreds of billions of dollars in recent years and is expected to approach more than a trillion dollars over the next decade, with growth varying by sector (pharmaceutical, agricultural, diagnostic).
Significant growth potential for biological products and R&D services across the region.
Focus on launch and validation of technology and processes.
Start sales and service contracts.
Achieve sales of several hundred million dollars, if fully operational with market development and required licenses.
Location in a Free Zone
Synergy with AFRA Pharma
Development of indigenous technologies
Focus on regional exports
Ability to provide CRO and CDMO services
Obtaining specialized licenses
Providing advanced equipment
Attracting specialized human resources
International competition
Currency fluctuations and supply chain
Reach out to the AFRA Holding team to discuss this venture in more detail.